Tempest Therapeutics shares head back to earth after 4,000% gain By: MarketWatch October 12, 2023 at 12:49 PM EDT Oncology company's stock drops more than 50% as it seeks partners to help advance investigational cancer treatment. Read More >> Related Stocks: Roche Holding AG Basel American Depositary Shares Tempest Therapeutics, Inc. - Common Stock
